373 related articles for article (PubMed ID: 16257536)
21. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
22. Vaccination against feline retroviruses.
Jarrett O
Dev Biol Stand; 1990; 72():185-8. PubMed ID: 2178114
[No Abstract] [Full Text] [Related]
23. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.
Yamamoto JK; Hohdatsu T; Olmsted RA; Pu R; Louie H; Zochlinski HA; Acevedo V; Johnson HM; Soulds GA; Gardner MB
J Virol; 1993 Jan; 67(1):601-5. PubMed ID: 8380095
[TBL] [Abstract][Full Text] [Related]
24. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
[TBL] [Abstract][Full Text] [Related]
25. Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency.
Assogba BD; Leavell S; Porter K; Burkhard MJ
J Infect Dis; 2007 Apr; 195(8):1184-8. PubMed ID: 17357056
[TBL] [Abstract][Full Text] [Related]
26. Clinical, hematologic, and survival data from cats infected with feline immunodeficiency virus: 42 cases (1983-1988).
Fleming EJ; McCaw DL; Smith JA; Buening GM; Johnson C
J Am Vet Med Assoc; 1991 Oct; 199(7):913-6. PubMed ID: 1663102
[TBL] [Abstract][Full Text] [Related]
27. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
Scott FW; Geissinger CM
Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
[TBL] [Abstract][Full Text] [Related]
28. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
[TBL] [Abstract][Full Text] [Related]
29. Feline immunodeficiency virus (FIV) neutralization: a review.
Hosie MJ; Pajek D; Samman A; Willett BJ
Viruses; 2011 Oct; 3(10):1870-90. PubMed ID: 22069520
[TBL] [Abstract][Full Text] [Related]
30. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
31. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
32. Comparison of diagnostic methods for feline leukemia virus and feline immunodeficiency virus.
Jarrett O; Pacitti AM; Hosie MJ; Reid G
J Am Vet Med Assoc; 1991 Nov; 199(10):1362-4. PubMed ID: 1666083
[No Abstract] [Full Text] [Related]
33. Neoplasia associated with feline immunodeficiency virus infection in cats of southern California.
Hutson CA; Rideout BA; Pedersen NC
J Am Vet Med Assoc; 1991 Nov; 199(10):1357-62. PubMed ID: 1666082
[TBL] [Abstract][Full Text] [Related]
34. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
Westman ME; Malik R; Hall E; Sheehy PA; Norris JM
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():43-52. PubMed ID: 26459979
[TBL] [Abstract][Full Text] [Related]
35. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
Stickney A; Ghosh S; Cave NJ; Dunowska M
Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
Broche-Pierre S; Richardson J; Moraillon A; Sonigo P
J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
[TBL] [Abstract][Full Text] [Related]
37. Prior virus exposure alters the long-term landscape of viral replication during feline lentiviral infection.
Zheng X; Carver S; Troyer RM; Terwee JA; VandeWoude S
Viruses; 2011 Oct; 3(10):1891-908. PubMed ID: 22069521
[TBL] [Abstract][Full Text] [Related]
38. Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination.
J Am Vet Med Assoc; 1991 Nov; 199(10):1273-7. PubMed ID: 1666068
[No Abstract] [Full Text] [Related]
39. Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses.
VandeWoude S; Hageman CL; Hoover EA
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):20-31. PubMed ID: 14501789
[TBL] [Abstract][Full Text] [Related]
40. Duration of antibody response following vaccination against feline immunodeficiency virus.
Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
